
The MiGel study is a clinical trial to investigate the potential effect of a topical medication for the treatment of vulval/vaginal pain with sexual activity.
Participants in the study need to be living in Australia, women aged 30 and over who also;
If you’re interested in participating in this study, please complete the survey below to check if the study is suitable for you and one of our team will contact you soon.
For the purpose of this study, you will be using either the active or placebo cream. For every three participants, two will receive the active cream and one will receive the placebo cream
If the study is suitable for you, our team will contact you. We will then email you the Patient Information and Consent Form, which takes approximately 10 -15 minutes to read. Next, we will arrange a 30 minute telehealth appointment with our study clinician. Once enrolled, you will participate in the study for 12 weeks.
There is one quick question to answer online each week, that should take less than one minute to complete.
There are 4 sets of survey questions to complete:
We estimate the longer surveys to take between 20-40 minutes, and the shorter surveys will take approximately 15 minutes to complete. Surveys are online so you can use your smartphone/computer.
The time estimated for the application of the study cream is about 2 minutes, twice a day including time to wash the syringe. We will provide a short video demonstration (3 minutes) on how to apply the cream and instructions on how to fill in the surveys.
Participants will receive compensation for time and inconvenience associated with the study.
No. All study visits are telehealth, so there is no travel involved.
If you are a healthcare provider considering referring a patient to this study and would like more information, please contact research@whria.com.au
Principal Investigator: Dr Karen Chan
Women’s Health & Research Institute of Australia
Level 12/97-99 Bathurst St, SYDNEY, NSW 2000
Study sponsor: TA Pharma Pty Ltd
Dr Karen Chan
Gynaecologist & Pain Specialist
© 2025 Women's Health & Research Institute of Australia. Privacy Policy | Terms of Use | Website by Phil Kurth